Arterial calcification: Cardiovascular function and clinical outcome

Nefrologia

Volumn 31, Issue 6, 2011, Pages 644-647

  London, G M ^a  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Arterial calcifications; Arterial stiffness; End stage renal disease

Indexed keywords

CALCIUM; PHOSPHATE; RUNX2 PROTEIN, HUMAN; SP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2;

ATHEROSCLEROSIS; CALCINOSIS; CELL DIFFERENTIATION; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTIMA; KIDNEY DISEASE; METABOLISM; OSTEOBLAST; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; SHORT SURVEY; TUNICA MEDIA; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ARTERIAL OCCLUSIVE DISEASES; ATHEROSCLEROSIS; CALCINOSIS; CALCIUM; CELL DIFFERENTIATION; CHRONIC DISEASE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MUSCLE, SMOOTH, VASCULAR; OSTEOBLASTS; PHOSPHATES; TRANSCRIPTION FACTORS; TUNICA INTIMA; TUNICA MEDIA; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84858322999     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Oct.11175     Document Type: Short Survey

References (39)

1. Lindner A, Chara M, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-702.
2. London GM, Drüeke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997;51:1678-95.
3. Pannier B, Guérin AP, Marchais SJ. Arterial structure and function in end-stage renal disease. Artery Research 2007;1:79-88.
4. Braun J, Oldendorf M, Moshage W. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
5. Goodman WG, Goldin J, Kuizon BD Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.
6. Guérin AP, London GM, Marchais SJ, Métivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-21.
7. Wilson PWF, Kauppila LI, O'Donnell CJ. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001;103:1529-34.
8. Keelan PC, Bielak LF, Ashai K. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001;104:412-7.
9. London GM, Guérin AP, Marchais SJ. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-40.
10. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1599-605.
11. Wang AY, Wang M, Woo J. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003;14:159-68.
12. Hayden MR, Tyagi SC, Kolb L. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging rolo of sodium thiosulfate. Cardiovasc Diabetol 2005;4:4.
13. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008;73:384-90.
14. Demer LL, Tintut Y. Vascular calcification: pathobiology of multifaceted disease. Circulation 2008;117:2938-48.
15. Reynolds JL, Joannides AJ, Skepper JN. Human Vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-67.
16. Steitz SA, Speer ME, Curinga G. Smooth muscle cell phenotypic transition associated with calcification. Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-54.
17. Shao J-S, Cheng SL, Sadhu J, Towler DA. Inflammation and the osteogenic regulation of vascular calcification. A review and perspective. Hypertension 2010;55:579-92.
18. Parhami F, Morrow AD, Balucan J. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differenciation: a possible explanation for the paradox of arterial calcification in osteoporosis patients. Arterioscler Thromb Vasc Biol 1997;17:680-7.
19. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001;31:509-19.
20. Wang TJ, Larson MG, Levy D. C-Reactive protein is associated with subclinical epicardial coronary calcification in men and women the Framingham Heart Study. Circulation 2002;106:1189-91.
21. Koh JM, Khang YH, Jung CH. Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005;16:1263-71.
22. Aikawa E, Nahrendorf M, Figuiredo JL. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 2007;116:2841-50.
23. Tintut Y, Patel J, Territo M. Monocyte macrophage regulation of vascular calcification in vitro. Circulation 2002;105:650-5.
24. Moe SM, Duan D, Doehle BP. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003;63:1003-11.
25. Lomashvili K, Cobbs S, Hennigar RA. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004;15:1392-401.
26. Zhao MM, Xu MJ, Cai Y. Mitochondrial reactive oxygen species promote p85 nuclear translocation mediating high phosphateinduced vascular calcification in vitro and in vivo. Kidney Int 2011;79:1071-9.
27. Schafer C, Heiss A, Schwarz A. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
28. Luo G, Ducy P, McKee MD. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
29. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. J Thromb Haemost 2003;1:178-85.
30. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cells: inhibition by osteopontin. Circ Res 1999;84:166-78.
31. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001;21:1610-6.
32. Lin TC, Tintut Y, Lyman A, Demer LL, Hsiai TK. Mechanical response of a calcified plaque model to fluid shear force. Ann Biomed Engl 2006;34:1535-41.
33. Hoshino T, Chow LA, Hsu JJ. Mechanical stress analysis of rigid inclusion in distensible material: a model of atherosclerotic calcification and plaque vulnerability. Am J Physiol Heart Circ Physiol 2009;297:H802-H810.
34. Guérin AP, London GM, Marchais SJ, Métivier F. Arterial stiffness and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-21.
35. O'Rourke MF. Mechanical principles in arterial disease. Hypertension 1995;26:2-9.
36. Brandenburg VM, Floege J. Adynamic bone disease-bone and beyond. NDT Plus 2008;3:135-47.
37. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patient. Kidney Int 2002;62:245-52.
38. Suki WN, Zabaneh R, Cangiano JL. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 2007;72:1130-7.
39. Bolland MJ, Barber PA, Doughty RN. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262-6.